Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Fonseca

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|November 5, 2019
Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic SclerosisSvetlana I Nihtyanova, Alper Sari, Jennifer C Harvey, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2018
Molecular Basis for Dysregulated Activation of NKX2-5 in the Vascular Remodeling of Systemic SclerosisAthina Dritsoula, Ioannis Papaioannou, Sandra G Guerra, et al.
Arthritis and Rheumatism|September 2, 2006
Endothelin axis polymorphisms in patients with sclerodermaCarmen Fonseca, Elizabeth Renzoni, Piersante Sestini, et al.
Annals of the Rheumatic Diseases|January 20, 2018
Changes in macrophage transcriptome associate with systemic sclerosis and mediate <i>GSDMA</i> contribution to disease riskAida Moreno-Moral, Marta Bagnati, Surya Koturan, et al.
The Journal of Rheumatology|March 17, 2020
Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal CrisisEdward P Stern, Sandra G Guerra, Harry Chinque, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
The New England Journal of Medicine|September 21, 2007
A polymorphism in the CTGF promoter region associated with systemic sclerosisCarmen Fonseca, Gisela E Lindahl, Markella Ponticos, et al.
Science (New York, N.Y.)|October 30, 2025
FIGNL1 inhibits homologous recombination in BRCA2 deficient cells by dissociating RAD51 filamentsRaviprasad Kuthethur, Safa Nasrin Vz, Satheesh Kumar Sengodan, et al.
Annals of the Rheumatic Diseases|October 2, 2020
Genomic Risk Score impact on susceptibility to systemic sclerosisLara Bossini-Castillo, Gonzalo Villanueva-Martin, Martin Kerick, et al.
Journal of Clinical Medicine|October 27, 2022
The Effect of Body Fat Distribution on Systemic SclerosisGonzalo Villanueva-Martin, Marialbert Acosta-Herrera, Martin Kerick, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Arthritis & Rheumatology (Hoboken, N.J.)|November 5, 2019
Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic SclerosisSvetlana I Nihtyanova, Alper Sari, Jennifer C Harvey, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 18, 2018
Molecular Basis for Dysregulated Activation of NKX2-5 in the Vascular Remodeling of Systemic SclerosisAthina Dritsoula, Ioannis Papaioannou, Sandra G Guerra, et al.
Arthritis and Rheumatism|September 2, 2006
Endothelin axis polymorphisms in patients with sclerodermaCarmen Fonseca, Elizabeth Renzoni, Piersante Sestini, et al.
Annals of the Rheumatic Diseases|January 20, 2018
Changes in macrophage transcriptome associate with systemic sclerosis and mediate <i>GSDMA</i> contribution to disease riskAida Moreno-Moral, Marta Bagnati, Surya Koturan, et al.
The Journal of Rheumatology|March 17, 2020
Analysis of Anti-RNA Polymerase III Antibody-positive Systemic Sclerosis and Altered GPATCH2L and CTNND2 Expression in Scleroderma Renal CrisisEdward P Stern, Sandra G Guerra, Harry Chinque, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
The New England Journal of Medicine|September 21, 2007
A polymorphism in the CTGF promoter region associated with systemic sclerosisCarmen Fonseca, Gisela E Lindahl, Markella Ponticos, et al.
Science (New York, N.Y.)|October 30, 2025
FIGNL1 inhibits homologous recombination in BRCA2 deficient cells by dissociating RAD51 filamentsRaviprasad Kuthethur, Safa Nasrin Vz, Satheesh Kumar Sengodan, et al.
Annals of the Rheumatic Diseases|October 2, 2020
Genomic Risk Score impact on susceptibility to systemic sclerosisLara Bossini-Castillo, Gonzalo Villanueva-Martin, Martin Kerick, et al.
Journal of Clinical Medicine|October 27, 2022
The Effect of Body Fat Distribution on Systemic SclerosisGonzalo Villanueva-Martin, Marialbert Acosta-Herrera, Martin Kerick, et al.
Pageof 5